Today we want to highlight a researcher whose work has made great strides to expand Alzheimer’s disease research, Dr. Goldie Byrd. Dr. Byrd, now the director of the Maya Angelou Center for Health Equity, has been contributing to Alzheimer’s research for over 15 years.
The Alzheimer’s Association (AA) recently announced they have invested $100 million into Alzheimer’s disease and dementia research initiatives this year. The organization came close last year, with a total of $90 million spent on research in 2022.
Throughout the holiday season, our hearts are filled with anticipation and joy, looking forward to spending time with family and creating cherished memories. Nevertheless, this time of year can bring unique challenges and uncertainties for families with loved ones living with Alzheimer’s disease or dementia.
Procter & Gamble (P&G) is a multi-national personal goods and consumer goods company known for its wide range of products, including well-known brands like Pampers, Tide, Crest, and Gillette. P&G is committed to corporate social responsibility and works with organizations like the Alzheimer’s Association to raise awareness and funding for research and support.
A Virtual Dementia Tour provides the opportunity for caregivers and healthcare providers to experience a simulated reality of what life is like for someone with dementia. It is a unique learning experience that builds empathy and awareness in individuals caring for people living with dementia.
Over 7,000 researchers and Alzheimer’s advocates from around the world gathered in Amsterdam this summer for the 2023 Alzheimer’s Association International Conference (AAIC). The AAIC is the world’s largest dementia research conference, providing a great opportunity for students and professionals to learn about the latest research on Alzheimer’s disease and dementia.
Alzheimer’s disease (AD) causes a gradual decline in memory, thinking, and reasoning skills. Symptoms depend on the stage of the disease. In this three-part article series, we discuss early-stage symptoms, middle-stage symptoms, and late-stage symptoms exhibited by individuals diagnosed with AD.
Alzheimer’s disease (AD) causes a gradual decline in memory, thinking, and reasoning skills. Symptoms depend on the stage of the disease. In this three-part article series, we discuss early-stage symptoms, middle-stage symptoms, and late-stage symptoms exhibited by individuals diagnosed with AD.
Alzheimer’s disease (AD) causes a gradual decline in memory, thinking, and reasoning skills. Symptoms depend on the stage of the disease. In this three-part article series, we discuss early-stage symptoms, middle-stage symptoms, and late-stage symptoms exhibited by individuals diagnosed with AD.
More than a hundred years ago, a German psychiatrist named Dr. Alois Alzheimer made an important discovery about a disease that would later bear his name. This discovery helped us learn more about the disease and laid the foundation for subsequent research and treatment.
